FDA

The tests, which had expired in late December, are earmarked for emergency management offices, county health departments, hospitals and long-term care facilities.

Aduhelm is the first treatment approved in the country to slow cognitive decline in those living with Alzheimer's. Doctors have refused to prescribe it, given the lack of data and evidence behind it.

The authorization comes in the midst of an explosion of COVID-19 cases nationwide driven by the omicron variant — a surge that has brought a spike in pediatric hospitalizations.

The Food and Drug Administration this week approved an injectable drug that helps prevent the spread of HIV. It only has to be taken once every eight weeks, compared to a daily oral pill.

The medicine, called molnupiravir, is taken twice a day for five days and works by preventing the virus from replicating. Merck says it will have 10 million packs available by the end of the month.

Moffitt Cancer Center in Tampa helped study the imaging drug, which the FDA recently approved. It draws attention to hard-to-spot tumors during surgery.

The Pfizer treatment could help keep people infected with the coronavirus from getting so sick that they need to be hospitalized.

With opioid overdoses surging, harm-reduction groups are calling on the FDA to change naloxone's prescription-only status. This would make it easier to get the lifesaving drug to people at risk.

Experts weigh in as the federal government urges everyone to get boosted amid concerns over omicron, a new covid variant.

Pfizer's CEO says the vaccine maker has asked federal regulators to authorize boosters for 16- and 17-year-olds. Currently, only people 18 and over are eligible for a booster in the U.S.